Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Imagion Biosystems Ltd. ( (AU:IBX) ) has provided an announcement.
Imagion Biosystems Limited has reported the cessation of a tranche of listed options on the ASX, identified by the code IBXAAA, which expired unexercised on 1 May 2026. The expiry of 68,750 options with an exercise price of $1.12 slightly reduces the company’s pool of potential dilutive securities, simplifying its capital structure and marginally adjusting prospective equity overhang for existing shareholders.
The notification, lodged as an Appendix 3H, confirms that these options lapsed purely due to expiry and not through conversion into ordinary shares. This administrative update has limited immediate operational impact but provides investors with greater clarity on Imagion Biosystems’ issued capital and contributes to more accurate assessment of future dilution and valuation metrics.
More about Imagion Biosystems Ltd.
Imagion Biosystems Limited, listed on the ASX under the code IBX, operates in the biotechnology and medical technology sector. The company focuses on developing diagnostic and imaging solutions, leveraging advanced biosystems technologies for healthcare and life sciences applications.
Average Trading Volume: 1,956,199
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$8.34M
Learn more about IBX stock on TipRanks’ Stock Analysis page.